Global Vaccine Contract Development and Manufacturing Organization (CDMO) Market is poised to grow at 8-10% CAGR to reach $5 billion by 2025

The global Vaccine CDMO market is driven by increased demand from biotech vaccine developers & more selective outsourcing by pharmaceutical companies. 

Vaccine manufacturing is a highly complex process compared to small molecules. Currently, the penetration of CDMO is less than 20% of overall manufacturing value with ample opportunity for growth. There is growing trend towards outsourcing by the pharma and biotech industry for vaccine development and manufacturing. While biotech companies largely lack internal capabilities on process development and in-house manufacturing facilities qualified with GMP or BSL1 or BSL2 levels; big pharma companies mainly approach CDMOs for high volume vaccine manufacturing, risk mitigation and fill and finish activities. Also, large pharma may struggle to meet rising demand for new technology vaccines like viral vector and mRNA. Moreover, increased interest in development of newer vaccines like shingles, RSV, infectious diseases by smaller biotech companies, will in turn offer growth opportunities for vaccine CDMOs.

To Get Customized Report, Contact Us @ https://meditechinsights.com/contact-us/

Based on our research & interviews with industry experts, currently, CDMOs derive most of their revenues from commercial manufacturing (drug substance/drug product manufacturing (including fill-n-finish) however, increasingly the pharma biotech companies are reaching out to CDMOs for development services as well.

“Propensity to outsource increases post development phase to lower capital investment, gain access to specific technologies, and maintain capacity flexibility.”

– Former VP, Supply Development, Vaccine Big Pharma, US

Medi-Tech Insights’ latest report on Vaccine CDMOs analyses the global Vaccine CDMO market with respect to service type, scale of operation, technology, end user, and region.

While majority volumes for vaccines are driven by emerging countries, most of the value is driven by North America & Europe. By technology, mRNA have great potential but other technologies like live-attenuated, inactivated and subunit will remain important in Vaccine CDMO Market.

Competitive Landscape: Vaccine CDMO Market

There are limited number of CDMOs who are able to offer full service and have expertise in newer platforms like mRNA/viral vector. Some of the leading players operating in the Vaccine CDMO market are Lonza, Catalent, Patheon, IDT, Wuxi Biologics, Fujifilm, and Emergent BioSolutions. On the other hand, there are several promising players in the global Vaccine CDMO market such as Halix, Cobra Biologics, Wacker, Batavia Biosciences, Biovian, Novasep, and Vibalogics. Among Asian players, Wuxi Biologics, SK Bioscience, and Samsung Biologics are expected to compete with Western players (using their US/EU presence) in the Vaccine CDMO market. The research report on global Vaccine CDMO market provides detailed analysis of key players with respect to their business and financial overview, competitive positioning, key growth strategies, and developments.

Sources: Medi-Tech Insights Analysis, Expert Interviews

For More Detailed Insights on, Contact Us @ https://meditechinsights.com/contact-us/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more

Global Drug Discovery Software market valued at $2 billion in 2020, is projected to grow at a healthy CAGR of 14% to reach $3.5 billion by 2025

The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and move towards web/cloud-based software. Global Drug Discovery Software Market – Niche but Fast-Growing Market The worldwide drug discovery software market is niche and growing rapidly, driven by the rising pressure on the pharma and biotech companies to cut costs in the research and preclinical stage of drug development, reduce timelines and improve transparency through deep learning software tools. “ Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge .” - Exe
Read more